Journal
REDOX REPORT
Volume 23, Issue 1, Pages 25-28Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/13510002.2017.1343223
Keywords
Neurodegenerative diseases; phytochemicals; quinolinic acid; kynurenine; Huntington's disease; free radicals; oxidative stress; antioxidant
Categories
Ask authors/readers for more resources
Objective: The objective of this paper was to link the phytochemical and metabolic research treating quinolinic acid induced oxidative stress in neurodegenerative disorders. Methods: Quinolinic acid, a metabolite of the kynurenine pathway of tryptophan catabolism, plays a role in the oxidative stress associated with many neurological disorders and is used to simulate disorders such as Parkinson's disease. Results: In these models, phytochemicals have been shown to reduce striatal lesion size, reduce inflammation and prevent lipid peroxidation caused by quinolinic acid. Conclusion: These results suggest that phenolic compounds, a class of phytochemicals, including flavonoids and diarylheptanoids, should be further studied to develop new treatments for oxidative stress related neurological disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available